These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38151884)

  • 41. Botulinum toxin-A for the treatment of neuralgia: a systematic review and meta-analysis.
    Meng F; Peng K; Yang JP; Ji FH; Xia F; Meng XW
    J Pain Res; 2018; 11():2343-2351. PubMed ID: 30349359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum toxin for myofascial pain syndromes in adults.
    Soares A; Andriolo RB; Atallah AN; da Silva EM
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD007533. PubMed ID: 25062018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of botulinum toxin in the treatment of bruxism: Systematic review.
    Fernández-Núñez T; Amghar-Maach S; Gay-Escoda C
    Med Oral Patol Oral Cir Bucal; 2019 Jul; 24(4):e416-e424. PubMed ID: 31246937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia.
    Leyden JE; Moss AC; MacMathuna P
    Cochrane Database Syst Rev; 2014; 2014(12):CD005046. PubMed ID: 25485740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.
    James E; Ellis C; Brassington R; Sathasivam S; Young CA
    Cochrane Database Syst Rev; 2022 May; 5(5):CD006981. PubMed ID: 35593746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Botulinum toxin type B for cervical dystonia.
    Marques RE; Duarte GS; Rodrigues FB; Castelão M; Ferreira J; Sampaio C; Moore AP; Costa J
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004315. PubMed ID: 27176573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Botulinum toxin treatment of temporomandibular joint pain in patients with bruxism: A prospective and randomized clinical study.
    Kaya DI; Ataoglu H
    Niger J Clin Pract; 2021 Mar; 24(3):412-417. PubMed ID: 33723117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review.
    Ataran R; Bahramian A; Jamali Z; Pishahang V; Sadeghi Barzegani H; Sarbakhsh P; Yazdani J
    J Dent (Shiraz); 2017 Sep; 18(3):157-164. PubMed ID: 29034269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intramuscular botulinum toxin injection additional to arthrocentesis in the management of temporomandibular joint pain.
    Ivask O; Leibur E; Akermann S; Tamme T; Voog-Oras Ü
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):e99-e106. PubMed ID: 27496577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Botulinum toxin type A therapy for cervical dystonia.
    Castelão M; Marques RE; Duarte GS; Rodrigues FB; Ferreira J; Sampaio C; Moore AP; Costa J
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003633. PubMed ID: 29230798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Botulinum toxin A treatment for post-herpetic neuralgia: A systematic review and meta-analysis.
    Li XL; Zeng X; Zeng S; He HP; Zeng Z; Peng LL; Chen LG
    Exp Ther Med; 2020 Feb; 19(2):1058-1064. PubMed ID: 32010269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of rehabilitation on reducing pain in muscle-related temporomandibular disorders: A systematic review and meta-analysis of randomized controlled trials.
    Ferrillo M; Ammendolia A; Paduano S; Calafiore D; Marotta N; Migliario M; Fortunato L; Giudice A; Michelotti A; de Sire A
    J Back Musculoskelet Rehabil; 2022; 35(5):921-936. PubMed ID: 35213347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
    Jadhao VA; Lokhande N; Habbu SG; Sewane S; Dongare S; Goyal N
    Indian J Dent Res; 2017; 28(5):493-497. PubMed ID: 29072209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle.
    Witteveen AG; Hofstad CJ; Kerkhoffs GM
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010643. PubMed ID: 26475434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Botulinum toxin type A therapy for cervical dystonia.
    Rodrigues FB; Duarte GS; Marques RE; Castelão M; Ferreira J; Sampaio C; Moore AP; Costa J
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003633. PubMed ID: 33180963
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does Adjunctive Botulinum Toxin A Reduce Pain Scores When Combined With Temporomandibular Joint Arthroscopy for the Treatment of Concomitant Temporomandibular Joint Arthralgia and Myofascial Pain?
    Thomas NJ; Aronovich S
    J Oral Maxillofac Surg; 2017 Dec; 75(12):2521-2528. PubMed ID: 28500876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Promising minimally invasive treatment modalities for symptomatic temporomandibular joint disc displacement with reduction: a randomized controlled clinical trial.
    Rady NA; Bahgat MM; Abdel-Hamid AM
    BMC Oral Health; 2022 Dec; 22(1):547. PubMed ID: 36456937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of electrical stimulation as an adjunct to botulinum toxin type A in the treatment of adult spasticity: a systematic review.
    Intiso D; Santamato A; Di Rienzo F
    Disabil Rehabil; 2017 Oct; 39(21):2123-2133. PubMed ID: 27764971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adjunct therapies to improve outcomes after botulinum toxin injection in children: A systematic review.
    Mathevon L; Bonan I; Barnais JL; Boyer F; Dinomais M
    Ann Phys Rehabil Med; 2019 Jul; 62(4):283-290. PubMed ID: 30063979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Botulinum Toxin on Equinus Foot Deformity in Cerebral Palsy Patients: A Systematic Review and Network Meta-analysis.
    Fathi M; Hussein AS; M Elghazaly S; Al-Kinawy AM; Abdeltawab AK; Mansour YM; Elbehbeh NA; Sherif A; Afifi AM
    Curr Pharm Des; 2020; 26(37):4796-4807. PubMed ID: 32418518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.